Bibliography
- DOUGHERTY TJ, BARRETT JF, PUCCI MJ: Microbial genomics and novel antibiotic discovery: new technology to search for new drugs. Curr. Phann. Des. (2002) 8:1119–1135.
- •A thoughtful review of the process for the identification and validation of novel antibacterial targets generated by bioinformatics-based genomics and their potential for new drug discovery.
- SUTCLIFFE JA: Antibacterial agents: solutions for the evolving problems of resistance. Bioorg. Med. Chem. Lett. (2003) 13:4159–4161.
- •Sobering drug resistance statistics for hospital and community pathogens that mitigate against relying solely on generic or soon-to-be generic antibacterials and argue for continuing Sisyphian search for new antibacterials.
- SHLAES DM: The abandonment of antibacterials: why and wherefore? Curr. Opin. Pharmacol (2003) 3:470–473.
- PROJAN SJ: Why is big Pharma getting out of antibacterial drug discovery? Curl: Opin. Microbial. (2003) 6:427–430.
- ZHANEL GG, HOBAN DJ: Ketolides in the treatment of respiratory infections. Expert Opin. Pharmacother (2002) 3:277–297.
- WALLER AS, CLEMENTS JM: Novel approaches to antimicrobial therapy: peptide deformylase. Curl: Opin. Drug Discov. Dev. (2002) 5:785–792.
- •An excellent review of peptide deformylase as an antibacterial target.
- HANSEN JL, MOORE PB, STEITZ TA: Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. J. Mol Biol. (2003) 330:1061–1075.
- •First report of anisomycin, chloramphenicol, sparsomycin, blasticidin S, and virginiamycin M bound to the large ribosomal subunit of Haloarcula marismortui at 3 A resolution. Binding sites are shown to overlap with those of peptidyl-tRNA or aminoacyl-tRNA, consistent with competitive inhibition of peptide bond formation.
- HEBEISEN P, HEINZE-KRAUSS I, ANGEHRN P, HOHL P, PAGE MGP, THEN RL: LI vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. (2001) 45:825–836.
- RICE LB, BONOMO RA: Beta-lactamases: which ones are clinically important? Drug Resist. Update (2000) 3:178–189.
- •An excellent review of clinically important 13-lactamases, particularly serine enzymes of Ambler Class A and C. It also discusses the growing importance of metalloenzymes of Ambler Class B.
- MASCARETTI OA, DANELON GO, LABORDE M, MATA EG, SETTI EL: Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors. Curl: Pharm. Dec. (1999) 5:939–953.
- FARMER TH, DEGNAN BA, PAYNE DJ:Penetration of beta-lactamase inhibitors into the periplasm of Gram-negative bacteria. FEMS Microbiol Lett. (1999) 176:11–15.
- LI XZ, ZHANG L, SRIKUMAR R, POOLE K: Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aerugMosa. Antimicrob. Agents Chemother (1998) 42:399–403.
- TEDESCO KL, RYBAK MJ: Daptomycin. Pharmacotherapy (2004) 24:41–57.
- SAFDAR N, ANDES D, CRAIG WA: In vivo pharmacodynamic activity of daptomycin. Antimicrob. Agents Chemother (2004) 48:63–68.
- LEVY SB: The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J Antimicrob. Chemother (2002) 49:25–30.
- ALEKSHUN MN, LEVY SB, MEALY TR, SEATON BA, HEAD JF: The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat. Struct. Biol. (2001) 8:710–714.
Websites
- http://www.datamonitoccom Datamonitor business intelligence website.
- http://www.merck.com Merck & Co. website.
- http://www.fda.gov/cder US FDA Center for Drug Evaluation and Research website.
- http://www.enanta.com Enanta Pharmaceuticals website.
- http://www. novartis. com Novartis homepage.
- http://www.vicuron.com Vicuron Pharmaceuticals website.
- http://www.rib-x.com Rib-X Pharmaceuticals website.
- http://www.vrtx.com Vertex Pharmaceuticals website.
- http://www.quorex.com Quorex Pharmaceuticals website.
- http://www.basileapharma.com Basilea Pharmaceutica AG website.
- http://www.methylgene.com MethylGene homepage.
- http://www.cubist.com Cubist Pharmaceuticals website.
- http://www.paratekpharm.com Paratek Pharmaceuticals website.